21-34449477-A-C
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM1PM2PM5PP3
The NM_000219.6(KCNE1):c.158T>G(p.Phe53Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. F53S) has been classified as Uncertain significance.
Frequency
Consequence
NM_000219.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
KCNE1 | NM_000219.6 | c.158T>G | p.Phe53Cys | missense_variant | 4/4 | ENST00000399286.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
KCNE1 | ENST00000399286.3 | c.158T>G | p.Phe53Cys | missense_variant | 4/4 | 1 | NM_000219.6 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 16
GnomAD4 exome Cov.: 22
GnomAD4 genome ? Cov.: 16
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Mar 12, 2012 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. KCNE1 p.Phe53Cys Based on the data reviewed below, we consider this a variant of uncertain significance, likely disease causing. This variant is novel. This is a non-conservative amino acid change with neutrally charged Phenylalanine replaced with a negatively charged Cysteine. Phenylalanine is highly conserved at this position across species and in silico analysis (Adzhubei et al 2010) predicts the amino acid change to be probably damaging to protein structure/function. Another variant at the same codon, p.Phe53Ser, has been reported in association with long QT syndrome in at least one individual (Napolitano et al 2005). Variants in nearby codons (p.Gly52Arg, p.Gly55Ser, p.Thr58Pro) have also been reported in association with long QT syndrome. The variant is not listed in dbSNP or the 1000 Genomes database. There is no variation at codon 53 currently listed in the NHLBI Exome Sequencing Project dataset, which includes variant calls on approximately 5000 Caucasian and African American individuals (as of March 1, 2012). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at